Fisher & Paykel Healthcare Corporation Limited
FSPKF
$16.93
-$1.99-10.50%
09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
---|---|---|---|---|---|
Net Income | 46.83M | 46.35M | 7.75M | 7.64M | 32.46M |
Total Depreciation and Amortization | 20.60M | 20.39M | 16.75M | 16.52M | 16.46M |
Total Amortization of Deferred Charges | -- | -- | 1.59M | 1.57M | -- |
Total Other Non-Cash Items | 825.40K | 816.80K | 51.69M | 50.98M | 484.00K |
Change in Net Operating Assets | 2.97M | 2.93M | 5.85M | 5.77M | -2.06M |
Cash from Operations | 71.23M | 70.49M | 83.63M | 82.49M | 47.34M |
Capital Expenditure | -12.11M | -11.98M | -16.20M | -15.98M | -79.83M |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -4.74M | -4.69M | -3.25M | -3.20M | -3.51M |
Cash from Investing | -16.84M | -16.67M | -19.45M | -19.18M | -83.34M |
Total Debt Issued | 20.00M | 20.00M | 45.30M | 45.30M | 105.00M |
Total Debt Repaid | -45.60M | -45.60M | -111.65M | -111.65M | -31.75M |
Issuance of Common Stock | 750.00K | 750.00K | 900.00K | 900.00K | 600.00K |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -22.03M | -21.80M | -15.93M | -15.71M | -20.35M |
Other Financing Activities | -7.72M | -7.72M | -5.89M | -5.89M | -7.21M |
Cash from Financing | -41.94M | -41.51M | -59.63M | -58.81M | 19.96M |
Foreign Exchange rate Adjustments | -1.56M | -1.54M | 428.70K | 422.90K | 242.00K |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 10.88M | 10.77M | 4.99M | 4.92M | -15.79M |